In 2023, experts decided against adding obesity drugs to the World Health Organisation's essential medicines list.

The U.S. Food and Drug Administration has accepted Novo Nordisk's marketing application for an oral version of its ...

More than a billion people now have obesity worldwide, according to the WHO, and around 70% of them live in low and ...

First, he landed his role in "Modern Family," a critically acclaimed ABC sitcom that went on for 11 seasons and catapulted ...

Young US women with breast cancer are not dying from the disease as often as a decade ago, researchers reported at the ...

GLP-1 drug prices are falling. That's good news for patients, but perhaps not such good news for pharmaceutical stock ...

NHS to trial prescribing the appetite-supressing drugs after a short consultation at a high street pharmacy as Government ...

In an internal memo, the World Health Organization signaled its support for anti-obesity drugs like Wegovy and Zepbound, ...

CVS Health said the drugs Wegovy and Saxenda from rival drugmaker Novo Nordisk will become the preferred options on its ...

The market for weight loss drugs is white-hot, and competition is heating up fast. This Danish company is already facing a ...